 Christopher Evans
Concepts (475)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mucins | 21 | 2022 | 59 | 4.080 |
Why?
| | Mucus | 13 | 2022 | 54 | 2.860 |
Why?
| | Mucin-5B | 22 | 2022 | 175 | 2.800 |
Why?
| | Lung | 36 | 2021 | 3664 | 2.180 |
Why?
| | Mucin 5AC | 16 | 2022 | 46 | 2.170 |
Why?
| | Mucociliary Clearance | 7 | 2021 | 43 | 2.060 |
Why?
| | Lung Diseases, Obstructive | 3 | 2023 | 44 | 1.800 |
Why?
| | Respiratory Mucosa | 16 | 2022 | 254 | 1.590 |
Why?
| | Idiopathic Pulmonary Fibrosis | 12 | 2022 | 451 | 1.470 |
Why?
| | Expectorants | 4 | 2023 | 24 | 1.330 |
Why?
| | Bronchial Hyperreactivity | 5 | 2015 | 95 | 1.040 |
Why?
| | Vagus Nerve | 4 | 2023 | 80 | 0.990 |
Why?
| | Bronchioles | 4 | 2024 | 23 | 0.930 |
Why?
| | Quantum Dots | 3 | 2012 | 34 | 0.920 |
Why?
| | Reflex | 1 | 2023 | 64 | 0.880 |
Why?
| | Respiratory System | 6 | 2020 | 141 | 0.870 |
Why?
| | Disulfides | 2 | 2022 | 91 | 0.810 |
Why?
| | Animals | 60 | 2023 | 33381 | 0.810 |
Why?
| | Mice | 42 | 2023 | 15520 | 0.790 |
Why?
| | Asthma | 8 | 2023 | 2158 | 0.780 |
Why?
| | Respiratory Hypersensitivity | 1 | 2021 | 65 | 0.770 |
Why?
| | Homeostasis | 6 | 2020 | 594 | 0.760 |
Why?
| | Alveolar Epithelial Cells | 2 | 2019 | 102 | 0.750 |
Why?
| | Lung Injury | 2 | 2021 | 210 | 0.690 |
Why?
| | Polymers | 2 | 2022 | 482 | 0.660 |
Why?
| | Eosinophilia | 1 | 2020 | 184 | 0.630 |
Why?
| | Disease Models, Animal | 17 | 2022 | 3730 | 0.630 |
Why?
| | Mice, Transgenic | 14 | 2020 | 2025 | 0.620 |
Why?
| | Mice, Inbred C57BL | 27 | 2022 | 4908 | 0.620 |
Why?
| | Hypersensitivity | 1 | 2021 | 268 | 0.600 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 9 | 2022 | 1137 | 0.580 |
Why?
| | Epithelial Cells | 10 | 2019 | 963 | 0.580 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 81 | 0.570 |
Why?
| | Receptors, Muscarinic | 4 | 2001 | 18 | 0.560 |
Why?
| | Selenium Compounds | 2 | 2012 | 21 | 0.550 |
Why?
| | Chalcogens | 2 | 2012 | 3 | 0.540 |
Why?
| | Cadmium Compounds | 2 | 2012 | 29 | 0.540 |
Why?
| | Pulmonary Alveoli | 3 | 2016 | 384 | 0.520 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 468 | 0.510 |
Why?
| | Macrophages | 3 | 2016 | 1324 | 0.490 |
Why?
| | Lung Diseases | 2 | 2018 | 718 | 0.460 |
Why?
| | Inflammation | 11 | 2022 | 2566 | 0.450 |
Why?
| | Eosinophils | 4 | 2021 | 282 | 0.450 |
Why?
| | Lung Neoplasms | 5 | 2018 | 2220 | 0.440 |
Why?
| | Cadmium | 1 | 2012 | 62 | 0.430 |
Why?
| | Cystic Fibrosis | 7 | 2021 | 964 | 0.420 |
Why?
| | Mice, Inbred BALB C | 8 | 2021 | 1206 | 0.420 |
Why?
| | Surface-Active Agents | 1 | 2012 | 81 | 0.420 |
Why?
| | Intracellular Space | 1 | 2012 | 69 | 0.410 |
Why?
| | Immunity, Innate | 5 | 2019 | 745 | 0.410 |
Why?
| | Uteroglobin | 5 | 2010 | 16 | 0.400 |
Why?
| | Promoter Regions, Genetic | 8 | 2018 | 1158 | 0.390 |
Why?
| | Ribonucleases | 3 | 2000 | 53 | 0.390 |
Why?
| | Organoselenium Compounds | 1 | 2010 | 16 | 0.380 |
Why?
| | Transcription Factors | 1 | 2018 | 1570 | 0.370 |
Why?
| | Bronchi | 3 | 2016 | 242 | 0.370 |
Why?
| | Cilia | 4 | 2022 | 160 | 0.360 |
Why?
| | Exocytosis | 3 | 2019 | 88 | 0.360 |
Why?
| | Mucous Membrane | 4 | 2021 | 113 | 0.330 |
Why?
| | Airway Obstruction | 2 | 2016 | 168 | 0.320 |
Why?
| | Intestinal Mucosa | 3 | 2022 | 531 | 0.320 |
Why?
| | Humans | 43 | 2024 | 118974 | 0.290 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2011 | 814 | 0.290 |
Why?
| | Alveolitis, Extrinsic Allergic | 2 | 2022 | 83 | 0.290 |
Why?
| | Ovalbumin | 7 | 2015 | 165 | 0.280 |
Why?
| | Munc18 Proteins | 2 | 2019 | 23 | 0.280 |
Why?
| | Gene Expression | 4 | 2018 | 1489 | 0.270 |
Why?
| | Colloids | 3 | 2019 | 60 | 0.260 |
Why?
| | Anti-Inflammatory Agents | 2 | 2015 | 465 | 0.260 |
Why?
| | Phagocytosis | 3 | 2016 | 364 | 0.250 |
Why?
| | Mice, Knockout | 12 | 2019 | 2680 | 0.250 |
Why?
| | Th2 Cells | 4 | 2017 | 164 | 0.240 |
Why?
| | Bronchoalveolar Lavage Fluid | 6 | 2022 | 613 | 0.230 |
Why?
| | Female | 31 | 2021 | 61565 | 0.230 |
Why?
| | Epoxy Resins | 1 | 2022 | 4 | 0.230 |
Why?
| | Glycosyltransferases | 1 | 2022 | 13 | 0.220 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2022 | 12 | 0.220 |
Why?
| | Gene Expression Regulation | 5 | 2018 | 2445 | 0.220 |
Why?
| | Physics | 1 | 2022 | 20 | 0.220 |
Why?
| | Receptor, Muscarinic M2 | 5 | 2005 | 8 | 0.220 |
Why?
| | Saccharopolyspora | 1 | 2022 | 6 | 0.220 |
Why?
| | Bronchiectasis | 1 | 2024 | 105 | 0.220 |
Why?
| | MicroRNAs | 3 | 2019 | 637 | 0.220 |
Why?
| | Glass | 1 | 2022 | 44 | 0.220 |
Why?
| | Glycoproteins | 2 | 2022 | 319 | 0.220 |
Why?
| | Golgi Apparatus | 1 | 2022 | 91 | 0.220 |
Why?
| | Liquid Crystals | 1 | 2022 | 42 | 0.210 |
Why?
| | Chemistry, Physical | 1 | 2022 | 40 | 0.210 |
Why?
| | Haemophilus influenzae | 4 | 2010 | 50 | 0.210 |
Why?
| | Genetic Predisposition to Disease | 5 | 2018 | 2275 | 0.210 |
Why?
| | Colon | 2 | 2022 | 238 | 0.210 |
Why?
| | Viscosity | 1 | 2022 | 83 | 0.210 |
Why?
| | Immunohistochemistry | 4 | 2015 | 1691 | 0.210 |
Why?
| | Pulmonary Eosinophilia | 1 | 2001 | 25 | 0.200 |
Why?
| | Sulfhydryl Compounds | 1 | 2023 | 179 | 0.200 |
Why?
| | Metaplasia | 5 | 2008 | 57 | 0.200 |
Why?
| | Pseudomonas Infections | 2 | 2020 | 193 | 0.190 |
Why?
| | Leukocyte Count | 1 | 2021 | 305 | 0.190 |
Why?
| | Substance P | 1 | 2000 | 44 | 0.190 |
Why?
| | Mustard Gas | 1 | 2021 | 93 | 0.190 |
Why?
| | Chemical Warfare Agents | 1 | 2021 | 103 | 0.190 |
Why?
| | Blood Proteins | 3 | 2000 | 248 | 0.180 |
Why?
| | Antigens | 4 | 2007 | 320 | 0.180 |
Why?
| | Syndecan-1 | 1 | 2019 | 30 | 0.180 |
Why?
| | Hypoxia | 2 | 2017 | 963 | 0.180 |
Why?
| | Male | 22 | 2021 | 57801 | 0.180 |
Why?
| | Gene Targeting | 2 | 2018 | 80 | 0.180 |
Why?
| | Allergens | 2 | 2015 | 424 | 0.180 |
Why?
| | Lymphocyte Subsets | 1 | 2019 | 76 | 0.180 |
Why?
| | Butadienes | 2 | 2009 | 33 | 0.170 |
Why?
| | Polystyrenes | 2 | 2009 | 33 | 0.170 |
Why?
| | Orthomyxoviridae Infections | 1 | 2019 | 53 | 0.170 |
Why?
| | Colitis, Ulcerative | 1 | 2020 | 105 | 0.170 |
Why?
| | Interleukin-13 | 3 | 2019 | 135 | 0.170 |
Why?
| | Temperature | 1 | 2022 | 622 | 0.170 |
Why?
| | Dexamethasone | 1 | 2001 | 320 | 0.170 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 2 | 2018 | 41 | 0.170 |
Why?
| | Receptors, Interleukin-1 | 1 | 2020 | 228 | 0.170 |
Why?
| | Cysts | 1 | 2019 | 93 | 0.170 |
Why?
| | Bone Marrow Cells | 2 | 2017 | 273 | 0.170 |
Why?
| | Bleomycin | 4 | 2022 | 228 | 0.170 |
Why?
| | Guinea Pigs | 5 | 2005 | 151 | 0.160 |
Why?
| | Extracellular Vesicles | 1 | 2019 | 76 | 0.160 |
Why?
| | Paraquat | 1 | 2018 | 14 | 0.160 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 462 | 0.160 |
Why?
| | Macrophage Activation | 1 | 2019 | 168 | 0.160 |
Why?
| | Herbicides | 1 | 2018 | 24 | 0.160 |
Why?
| | Signal Transduction | 8 | 2022 | 4709 | 0.160 |
Why?
| | Colitis | 1 | 2020 | 219 | 0.160 |
Why?
| | Methacholine Chloride | 2 | 2015 | 48 | 0.160 |
Why?
| | Thrombospondin 1 | 1 | 2017 | 22 | 0.150 |
Why?
| | Schistosoma | 1 | 2017 | 18 | 0.150 |
Why?
| | Mast Cells | 2 | 2021 | 115 | 0.150 |
Why?
| | Mucin-2 | 1 | 2016 | 3 | 0.150 |
Why?
| | Transgenes | 1 | 2018 | 174 | 0.150 |
Why?
| | Gene Expression Profiling | 4 | 2018 | 1597 | 0.150 |
Why?
| | Patient Outcome Assessment | 1 | 2018 | 122 | 0.150 |
Why?
| | Bacteria | 3 | 2020 | 757 | 0.150 |
Why?
| | Leukocytes | 2 | 2016 | 290 | 0.150 |
Why?
| | Carcinogenesis | 1 | 2018 | 182 | 0.150 |
Why?
| | Neurons | 2 | 2005 | 1345 | 0.140 |
Why?
| | Glucocorticoids | 1 | 2001 | 545 | 0.140 |
Why?
| | Bronchitis, Chronic | 1 | 2016 | 20 | 0.140 |
Why?
| | Cytokines | 6 | 2021 | 1900 | 0.140 |
Why?
| | Kartagener Syndrome | 1 | 2016 | 25 | 0.140 |
Why?
| | Bronchoconstriction | 2 | 2011 | 26 | 0.140 |
Why?
| | Pulmonary Gas Exchange | 1 | 2016 | 117 | 0.140 |
Why?
| | Glycosylation | 1 | 2016 | 129 | 0.140 |
Why?
| | Survival Analysis | 3 | 2018 | 1267 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 359 | 0.140 |
Why?
| | Neutrophils | 3 | 2017 | 1233 | 0.140 |
Why?
| | Thiocyanates | 1 | 2015 | 29 | 0.130 |
Why?
| | Qc-SNARE Proteins | 1 | 2015 | 7 | 0.130 |
Why?
| | Qb-SNARE Proteins | 1 | 2015 | 6 | 0.130 |
Why?
| | Idiopathic Interstitial Pneumonias | 1 | 2015 | 41 | 0.130 |
Why?
| | Aspergillus oryzae | 1 | 2015 | 3 | 0.130 |
Why?
| | Mutation | 5 | 2018 | 3457 | 0.130 |
Why?
| | Deoxycytidine Kinase | 1 | 2014 | 3 | 0.130 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2014 | 5 | 0.130 |
Why?
| | Models, Biological | 2 | 2013 | 1715 | 0.130 |
Why?
| | Polysaccharides | 1 | 2014 | 78 | 0.120 |
Why?
| | Transcription, Genetic | 2 | 2018 | 1323 | 0.120 |
Why?
| | Cell Line | 4 | 2019 | 2707 | 0.120 |
Why?
| | Acute Lung Injury | 1 | 2017 | 310 | 0.120 |
Why?
| | Microbiota | 1 | 2021 | 656 | 0.120 |
Why?
| | Species Specificity | 1 | 2015 | 565 | 0.120 |
Why?
| | Ear, Middle | 1 | 2013 | 92 | 0.120 |
Why?
| | Valerates | 1 | 2013 | 3 | 0.120 |
Why?
| | Bed Rest | 1 | 2013 | 16 | 0.110 |
Why?
| | Adenosine Triphosphate | 3 | 2022 | 439 | 0.110 |
Why?
| | Smoking | 2 | 2018 | 1487 | 0.110 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 2851 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 3 | 2015 | 404 | 0.110 |
Why?
| | Genes, Essential | 1 | 2012 | 22 | 0.110 |
Why?
| | Semiconductors | 1 | 2012 | 36 | 0.110 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 33 | 0.110 |
Why?
| | Muscle Development | 1 | 2013 | 102 | 0.110 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2012 | 49 | 0.110 |
Why?
| | Crystallization | 1 | 2012 | 146 | 0.110 |
Why?
| | Receptors, Immunologic | 1 | 2013 | 209 | 0.100 |
Why?
| | Polymerization | 1 | 2012 | 129 | 0.100 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 982 | 0.100 |
Why?
| | Adenocarcinoma | 1 | 2018 | 812 | 0.100 |
Why?
| | Bacterial Infections | 1 | 2013 | 227 | 0.100 |
Why?
| | Base Sequence | 3 | 2017 | 2159 | 0.100 |
Why?
| | Sarcopenia | 1 | 2013 | 72 | 0.100 |
Why?
| | Trichuris | 1 | 2011 | 3 | 0.100 |
Why?
| | Trichuriasis | 1 | 2011 | 4 | 0.100 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2011 | 11 | 0.100 |
Why?
| | Genes, ras | 2 | 2009 | 95 | 0.100 |
Why?
| | Antigens, Dermatophagoides | 1 | 2011 | 15 | 0.100 |
Why?
| | Eosinophil Granule Proteins | 3 | 2000 | 21 | 0.100 |
Why?
| | Chromosomes, Human, Pair 11 | 1 | 2011 | 66 | 0.100 |
Why?
| | Integrases | 2 | 2010 | 123 | 0.100 |
Why?
| | Sepsis | 1 | 2017 | 531 | 0.100 |
Why?
| | Immune Tolerance | 1 | 2013 | 334 | 0.100 |
Why?
| | Bronchial Provocation Tests | 2 | 2011 | 54 | 0.100 |
Why?
| | Phosphines | 1 | 2010 | 15 | 0.100 |
Why?
| | Th1 Cells | 1 | 2011 | 133 | 0.090 |
Why?
| | Goblet Cells | 2 | 2020 | 17 | 0.090 |
Why?
| | Reproducibility of Results | 1 | 2018 | 2874 | 0.090 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 394 | 0.090 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 968 | 0.090 |
Why?
| | Acute Kidney Injury | 1 | 2017 | 709 | 0.090 |
Why?
| | DNA Primers | 2 | 2009 | 533 | 0.090 |
Why?
| | Middle Aged | 7 | 2021 | 27617 | 0.090 |
Why?
| | Apoptosis | 3 | 2014 | 2484 | 0.090 |
Why?
| | Proteins | 1 | 2015 | 938 | 0.090 |
Why?
| | Latex | 1 | 2009 | 12 | 0.090 |
Why?
| | Pentanes | 1 | 2009 | 11 | 0.090 |
Why?
| | Hemiterpenes | 1 | 2009 | 13 | 0.090 |
Why?
| | Curcumin | 1 | 2009 | 33 | 0.090 |
Why?
| | Dietary Supplements | 1 | 2013 | 467 | 0.090 |
Why?
| | Elastomers | 1 | 2009 | 29 | 0.090 |
Why?
| | Emulsions | 1 | 2009 | 45 | 0.090 |
Why?
| | Respiratory Function Tests | 2 | 2021 | 526 | 0.080 |
Why?
| | Immunoenzyme Techniques | 2 | 2010 | 195 | 0.080 |
Why?
| | Thermodynamics | 3 | 2022 | 392 | 0.080 |
Why?
| | Respiratory System Agents | 1 | 2008 | 22 | 0.080 |
Why?
| | Cell Extracts | 1 | 2008 | 17 | 0.080 |
Why?
| | Pneumococcal Infections | 1 | 2009 | 96 | 0.080 |
Why?
| | Electric Stimulation | 2 | 2000 | 268 | 0.080 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2010 | 508 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2017 | 2657 | 0.080 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2015 | 180 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2017 | 2062 | 0.080 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2008 | 40 | 0.080 |
Why?
| | Gait | 1 | 2010 | 253 | 0.080 |
Why?
| | Recombination, Genetic | 1 | 2008 | 173 | 0.080 |
Why?
| | 3T3 Cells | 1 | 2007 | 141 | 0.070 |
Why?
| | PTEN Phosphohydrolase | 1 | 2008 | 143 | 0.070 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2009 | 304 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 207 | 0.070 |
Why?
| | Interleukin-6 | 1 | 2010 | 688 | 0.070 |
Why?
| | Receptor, Adenosine A3 | 1 | 2006 | 1 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2007 | 219 | 0.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 394 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 372 | 0.070 |
Why?
| | Walking | 1 | 2010 | 415 | 0.070 |
Why?
| | Gene Knockdown Techniques | 2 | 2017 | 311 | 0.070 |
Why?
| | Chemokines, CC | 1 | 2005 | 30 | 0.070 |
Why?
| | Time Factors | 3 | 2011 | 6412 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2005 | 45 | 0.070 |
Why?
| | Lung Diseases, Interstitial | 1 | 2011 | 464 | 0.070 |
Why?
| | Hypertension, Pulmonary | 1 | 2017 | 1794 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1510 | 0.070 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 317 | 0.070 |
Why?
| | Adolescent | 2 | 2021 | 18480 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2010 | 767 | 0.060 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 2004 | 2 | 0.060 |
Why?
| | Pseudomonas aeruginosa | 2 | 2018 | 305 | 0.060 |
Why?
| | Polyethylene Glycols | 1 | 2009 | 578 | 0.060 |
Why?
| | Pneumonia | 3 | 2017 | 592 | 0.060 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 237 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 2008 | 551 | 0.060 |
Why?
| | Aerosols | 3 | 2010 | 221 | 0.060 |
Why?
| | Adult | 3 | 2021 | 31512 | 0.060 |
Why?
| | Up-Regulation | 1 | 2007 | 872 | 0.060 |
Why?
| | Transcriptome | 2 | 2019 | 756 | 0.060 |
Why?
| | Trachea | 2 | 2020 | 226 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1515 | 0.060 |
Why?
| | Thermal Conductivity | 1 | 2022 | 5 | 0.060 |
Why?
| | Ethylenes | 1 | 2022 | 11 | 0.060 |
Why?
| | Age Factors | 1 | 2010 | 2995 | 0.060 |
Why?
| | Real-Time Polymerase Chain Reaction | 2 | 2014 | 333 | 0.060 |
Why?
| | Amino Acid Sequence | 1 | 2007 | 2071 | 0.060 |
Why?
| | Mice, Mutant Strains | 2 | 2015 | 280 | 0.060 |
Why?
| | Phase Transition | 1 | 2022 | 29 | 0.060 |
Why?
| | Aging | 1 | 2013 | 1670 | 0.060 |
Why?
| | Phenotype | 4 | 2014 | 3003 | 0.050 |
Why?
| | Diffusion | 1 | 2022 | 122 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2007 | 2871 | 0.050 |
Why?
| | Balantidiasis | 1 | 2001 | 1 | 0.050 |
Why?
| | Fibrosis | 1 | 2024 | 483 | 0.050 |
Why?
| | Mechlorethamine | 1 | 2021 | 58 | 0.050 |
Why?
| | ErbB Receptors | 2 | 2018 | 569 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 175 | 0.050 |
Why?
| | Antibodies | 2 | 2000 | 392 | 0.050 |
Why?
| | Quinuclidines | 1 | 2000 | 4 | 0.050 |
Why?
| | Neurokinin-1 Receptor Antagonists | 1 | 2000 | 9 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2020 | 71 | 0.050 |
Why?
| | Neutrophil Infiltration | 2 | 2012 | 97 | 0.050 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 827 | 0.050 |
Why?
| | Protein Binding | 2 | 2017 | 1975 | 0.050 |
Why?
| | Respiration | 1 | 2021 | 183 | 0.050 |
Why?
| | Protective Factors | 1 | 2020 | 92 | 0.050 |
Why?
| | Haemophilus Infections | 2 | 2010 | 31 | 0.050 |
Why?
| | Cyclophosphamide | 1 | 2000 | 222 | 0.050 |
Why?
| | Trichinellosis | 1 | 2019 | 2 | 0.050 |
Why?
| | Trichinella spiralis | 1 | 2019 | 2 | 0.050 |
Why?
| | Cross Protection | 1 | 2019 | 4 | 0.050 |
Why?
| | Keratin-15 | 1 | 2019 | 14 | 0.050 |
Why?
| | Cell Proliferation | 3 | 2014 | 2275 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 159 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2013 | 770 | 0.040 |
Why?
| | Surface Properties | 2 | 2012 | 397 | 0.040 |
Why?
| | Nippostrongylus | 1 | 2019 | 3 | 0.040 |
Why?
| | Strongylida Infections | 1 | 2019 | 6 | 0.040 |
Why?
| | Histamine | 1 | 1999 | 65 | 0.040 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 1 | 2019 | 33 | 0.040 |
Why?
| | Hyperplasia | 1 | 2019 | 170 | 0.040 |
Why?
| | Heparin | 1 | 2000 | 230 | 0.040 |
Why?
| | Biological Transport | 1 | 2020 | 382 | 0.040 |
Why?
| | Piperidines | 1 | 2000 | 171 | 0.040 |
Why?
| | Muscle Strength | 2 | 2013 | 283 | 0.040 |
Why?
| | Gain of Function Mutation | 1 | 2018 | 30 | 0.040 |
Why?
| | Biomarkers, Tumor | 2 | 2018 | 1059 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2018 | 74 | 0.040 |
Why?
| | Immunization | 1 | 2001 | 412 | 0.040 |
Why?
| | Sri Lanka | 1 | 2018 | 12 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2009 | 1974 | 0.040 |
Why?
| | Sputum | 1 | 2020 | 290 | 0.040 |
Why?
| | Interleukin-4 | 1 | 2019 | 215 | 0.040 |
Why?
| | Larva | 1 | 2019 | 213 | 0.040 |
Why?
| | Intestines | 1 | 2021 | 332 | 0.040 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2019 | 140 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2020 | 514 | 0.040 |
Why?
| | Immunologic Techniques | 1 | 1997 | 40 | 0.040 |
Why?
| | Analysis of Variance | 1 | 2001 | 1293 | 0.040 |
Why?
| | RNA Transport | 1 | 2017 | 22 | 0.040 |
Why?
| | Lipids | 1 | 2021 | 607 | 0.040 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2017 | 10 | 0.040 |
Why?
| | Body Composition | 2 | 2013 | 653 | 0.040 |
Why?
| | Neoplasms, Experimental | 1 | 2018 | 158 | 0.040 |
Why?
| | Chemokines | 2 | 2009 | 230 | 0.040 |
Why?
| | Antigens, Ly | 1 | 2017 | 45 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 736 | 0.040 |
Why?
| | Poly(ADP-ribose) Polymerases | 1 | 2017 | 87 | 0.040 |
Why?
| | Biopsy | 1 | 2001 | 1079 | 0.040 |
Why?
| | CpG Islands | 1 | 2017 | 119 | 0.040 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 136 | 0.040 |
Why?
| | Acetylcholine | 1 | 1997 | 208 | 0.040 |
Why?
| | Aged | 5 | 2015 | 19657 | 0.040 |
Why?
| | Epithelial Sodium Channels | 1 | 2016 | 12 | 0.040 |
Why?
| | NF-kappa B | 2 | 2012 | 670 | 0.040 |
Why?
| | Rabbits | 1 | 1997 | 780 | 0.040 |
Why?
| | ADAMTS9 Protein | 1 | 2015 | 5 | 0.030 |
Why?
| | Serpin E2 | 1 | 2015 | 5 | 0.030 |
Why?
| | Procollagen N-Endopeptidase | 1 | 2015 | 7 | 0.030 |
Why?
| | ADAMTS4 Protein | 1 | 2015 | 15 | 0.030 |
Why?
| | Serpins | 1 | 2015 | 26 | 0.030 |
Why?
| | Cell Communication | 1 | 2017 | 281 | 0.030 |
Why?
| | E-Selectin | 1 | 2015 | 52 | 0.030 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2015 | 34 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2015 | 3171 | 0.030 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2015 | 13 | 0.030 |
Why?
| | ADAM Proteins | 1 | 2015 | 59 | 0.030 |
Why?
| | Child | 3 | 2021 | 19129 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 219 | 0.030 |
Why?
| | Mucin-4 | 1 | 2014 | 3 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 1945 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 564 | 0.030 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 55 | 0.030 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 190 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2017 | 282 | 0.030 |
Why?
| | Cattle | 1 | 2017 | 978 | 0.030 |
Why?
| | Child, Preschool | 2 | 2021 | 9491 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 513 | 0.030 |
Why?
| | Pneumonia, Bacterial | 1 | 2015 | 110 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 246 | 0.030 |
Why?
| | Binding Sites | 1 | 2017 | 1224 | 0.030 |
Why?
| | Immunophenotyping | 1 | 2014 | 278 | 0.030 |
Why?
| | Nanoparticles | 1 | 2017 | 325 | 0.030 |
Why?
| | Administration, Inhalation | 1 | 2015 | 656 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 870 | 0.030 |
Why?
| | Musculoskeletal Physiological Phenomena | 1 | 2013 | 8 | 0.030 |
Why?
| | Whole Body Imaging | 1 | 2013 | 25 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2012 | 4077 | 0.030 |
Why?
| | Passive Cutaneous Anaphylaxis | 1 | 2012 | 5 | 0.030 |
Why?
| | E-Box Elements | 1 | 2012 | 5 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1012 | 0.030 |
Why?
| | DNA Methylation | 1 | 2017 | 503 | 0.030 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2012 | 27 | 0.030 |
Why?
| | Ligands | 1 | 2014 | 567 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 136 | 0.030 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2012 | 133 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 229 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2012 | 146 | 0.030 |
Why?
| | Macromolecular Substances | 1 | 2012 | 201 | 0.030 |
Why?
| | Cell Separation | 1 | 2013 | 296 | 0.030 |
Why?
| | Bronchoconstrictor Agents | 1 | 2011 | 15 | 0.030 |
Why?
| | Arthropod Proteins | 1 | 2011 | 4 | 0.030 |
Why?
| | Cecum | 1 | 2011 | 37 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2013 | 412 | 0.020 |
Why?
| | Muscle Proteins | 1 | 2013 | 219 | 0.020 |
Why?
| | Particle Size | 1 | 2012 | 345 | 0.020 |
Why?
| | Airway Resistance | 1 | 2011 | 33 | 0.020 |
Why?
| | Gene Deletion | 1 | 2012 | 361 | 0.020 |
Why?
| | Cysteine Endopeptidases | 1 | 2011 | 61 | 0.020 |
Why?
| | Stress, Mechanical | 1 | 2012 | 443 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 827 | 0.020 |
Why?
| | Resistance Training | 1 | 2013 | 120 | 0.020 |
Why?
| | Materials Testing | 1 | 2012 | 359 | 0.020 |
Why?
| | Habits | 1 | 2010 | 38 | 0.020 |
Why?
| | Linkage Disequilibrium | 1 | 2011 | 273 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2014 | 726 | 0.020 |
Why?
| | Transfection | 1 | 2012 | 888 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2436 | 0.020 |
Why?
| | Genetic Variation | 1 | 2015 | 926 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1419 | 0.020 |
Why?
| | Prognosis | 1 | 2018 | 3443 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1194 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2011 | 321 | 0.020 |
Why?
| | Tumor Burden | 1 | 2010 | 274 | 0.020 |
Why?
| | Cell Degranulation | 1 | 2009 | 38 | 0.020 |
Why?
| | Speech | 1 | 2010 | 76 | 0.020 |
Why?
| | Genotype | 1 | 2015 | 1882 | 0.020 |
Why?
| | Survival | 1 | 2009 | 39 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1085 | 0.020 |
Why?
| | Body Height | 1 | 2010 | 187 | 0.020 |
Why?
| | Immunoglobulin E | 1 | 2011 | 365 | 0.020 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 200 | 0.020 |
Why?
| | Physical Fitness | 1 | 2010 | 179 | 0.020 |
Why?
| | Physical Exertion | 1 | 2010 | 222 | 0.020 |
Why?
| | Molecular Weight | 1 | 2009 | 343 | 0.020 |
Why?
| | Antigens, Bacterial | 1 | 2009 | 116 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 876 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2015 | 1178 | 0.020 |
Why?
| | Organometallic Compounds | 1 | 2009 | 88 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2013 | 1687 | 0.020 |
Why?
| | Leg | 1 | 2010 | 234 | 0.020 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2008 | 82 | 0.020 |
Why?
| | Uridine Triphosphate | 1 | 2008 | 11 | 0.020 |
Why?
| | Ozone | 1 | 2009 | 109 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2008 | 138 | 0.020 |
Why?
| | Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 20 | 0.020 |
Why?
| | Colony Count, Microbial | 1 | 2008 | 120 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2009 | 181 | 0.020 |
Why?
| | Genetic Engineering | 1 | 2008 | 83 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2010 | 586 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2008 | 270 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2011 | 736 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 460 | 0.020 |
Why?
| | Exons | 1 | 2008 | 307 | 0.020 |
Why?
| | Gene Silencing | 1 | 2008 | 177 | 0.020 |
Why?
| | Tumor Suppressor Proteins | 1 | 2009 | 289 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2009 | 806 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 788 | 0.020 |
Why?
| | Cell Shape | 1 | 2006 | 57 | 0.020 |
Why?
| | Survival Rate | 1 | 2010 | 1720 | 0.020 |
Why?
| | Immunocompromised Host | 1 | 2008 | 200 | 0.020 |
Why?
| | Receptors, Interleukin-4 | 1 | 2005 | 15 | 0.020 |
Why?
| | Receptors, CCR3 | 1 | 2005 | 8 | 0.020 |
Why?
| | Chemokine CCL11 | 1 | 2005 | 22 | 0.020 |
Why?
| | Cell Survival | 1 | 2009 | 1047 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 369 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2008 | 341 | 0.020 |
Why?
| | Body Weight | 1 | 2010 | 934 | 0.020 |
Why?
| | Parasympathetic Nervous System | 1 | 2005 | 25 | 0.020 |
Why?
| | Motor Activity | 1 | 2010 | 660 | 0.020 |
Why?
| | Models, Genetic | 1 | 2008 | 595 | 0.020 |
Why?
| | Alleles | 1 | 2008 | 832 | 0.020 |
Why?
| | History, 20th Century | 1 | 2006 | 281 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1636 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2007 | 653 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2011 | 1323 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2015 | 5255 | 0.020 |
Why?
| | Endothelial Cells | 1 | 2009 | 732 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5392 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2007 | 1171 | 0.010 |
Why?
| | Young Adult | 1 | 2018 | 10793 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1167 | 0.010 |
Why?
| | Disease Progression | 1 | 2009 | 2490 | 0.010 |
Why?
| | Infant | 1 | 2015 | 8293 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2008 | 1055 | 0.010 |
Why?
| | Diamines | 1 | 1999 | 3 | 0.010 |
Why?
| | Integrin alpha4beta1 | 1 | 1999 | 7 | 0.010 |
Why?
| | Muscarinic Agonists | 1 | 1999 | 10 | 0.010 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 1999 | 16 | 0.010 |
Why?
| | Atropine | 1 | 1999 | 32 | 0.010 |
Why?
| | Vagotomy | 1 | 1999 | 34 | 0.010 |
Why?
| | Muscarinic Antagonists | 1 | 1999 | 25 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2010 | 6561 | 0.010 |
Why?
| | Integrins | 1 | 1999 | 82 | 0.010 |
Why?
| | Pregnancy | 1 | 2009 | 5691 | 0.010 |
Why?
|
|
Evans's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|